CLINICAL_TRIALS
trial_result
· 2019-08-08
Clinical Trial Update: Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations [Phase 2]
Summary
Phase 2 trial update evaluating trametinib in advanced melanoma with BRAF non-V600 mutations; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Recurrent Melanoma, Stage IIIB Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2019-08-08